EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis

Timothy R Keiffer iD, Stephen DiGiuseppe iD, Lucile Guion, Malgorzata Bienkowska-Haba iD, Katarzyna Zwolinska iD, Abida Siddiqa, Anand Kushwaha, Martin J Sapp iD

Journal of Virology · 31.01.2025 · 99 (1)

DOI: 10.1128/jvi.00937-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 31.01.2025. Verfasst von Timothy R Keiffer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Center for Molecular and Tumor Virology, Feist-Weiller Cancer Center, Louisiana State University Health Sc…. Hauptthemen laut MEDLINE: Kinesins, Mitosis, Dyneins, Microtubules. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomaviruses (HPVs) travel from the trans-Golgi network (TGN) to the condensed (mitotic) chromosomes during mitosis. Partially uncoated HPV capsids utilize a unique vesicular structure for trafficking and nuclear import, which is directed by the minor capsid protein L2. However, it is still unknown which precise factors facilitate post-TGN HPV trafficking to the nucleus. Herein, we analyzed HPV16-infected mitotic cells using high-resolution microscopy, coupled with motor protein inhibition, to further elaborate on post-TGN trafficking by tracking the location and/or quantification of EdU-labeled HPV pseudogenomes on microtubules, certain kinesins, and mitotic chromosomes. We also adapted a knocksideways approach to determine if L2 and Kif11 interact in infected cells. We visualized dynein co-localization with HPV pseudogenomes along mitotic microtubules and measured HPV pseudogenome accumulation after short-term dynein inhibition. Additional inhibitor studies implicated a specific kinesin, Kif11, as participating in HPV pseudogenome delivery to the nucleus. Short-term inhibition of Kif11 decreased HPV pseudogenome accumulation at mitotic chromatin. In addition, Kif11, along with kinesins Kif18a and Kif25, were in proximity to L2 during infection. While we were unable to determine a direct interaction between L2 and Kif11, we were able to show via knocksideways approach that relocalization of exogenous Kif11 decreased HPV pseudogenome accumulation to the mitotic chromatin. Our data support a model whereby HPV16 utilizes dynein for minus-end trafficking along mitotic microtubules and utilizes Kif11 for plus-end movement in the late stage of viral entry. IMPORTANCE Human papillomaviruses (HPV) utilize a unique vesicular structure to shield their genomes from detection during trafficking from the trans-Golgi network (TGN) to the nucleus during mitosis. The exact cellular factors responsible for trafficking these HPV genome containing vesicles along mitotic microtubules via the L2 minor protein remain unknown. We show via high-resolution microscopy that pharmacological inhibition of dynein and the kinesin Kif11 significantly decreases HPV pseudogenome accumulation on mitotic chromatin. Several kinesins were detected in proximity to incoming HPV pseudogenomes. Finally, using a novel knocksideways approach, we show reduced HPV pseudogenome accumulation on mitotic chromatin upon Kif11 relocalization to the mitochondria. Herein, our data suggest HPV utilizes minus- and plus-end mediated trafficking along mitotic microtubules to complete its genome trafficking to the nucleus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KinesinsMitosisDyneinsMicrotubulesHuman papillomavirus 16Virus InternalizationPapillomavirus InfectionsHumansCapsid ProteinsOncogene Proteins, Viraltrans-Golgi NetworkHeLa CellsCell NucleusProtein TransportBiological Transport

Stichwörter der Autor:innen

HPV16Kif11Kif18aKif25dyneinkinesinsknocksidewaysmicrotubulesmitosisproximity ligation assay

Substanzen

KinesinsDyneinsKIF11 protein, humanCapsid ProteinsOncogene Proteins, ViralL2 protein, Human papillomavirus type 16

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Center for Molecular and Tumor Virology, Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA.
  • Edward Via College of Osteopathic Medicine, Monroe, Louisiana, USA.

ORCID-Profile: Timothy R Keiffer, Stephen DiGiuseppe, Malgorzata Bienkowska-Haba, Katarzyna Zwolinska, Martin J Sapp

Förderung

  • NIAID NIH HHS

Zitieren

APA

Keiffer, T. R., DiGiuseppe, S., Guion, L., Bienkowska-Haba, M., Zwolinska, K., Siddiqa, A., Kushwaha, A., & Sapp, M. J. (2025). HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis. Journal of Virology, 99(1). https://doi.org/10.1128/jvi.00937-24

Vancouver

Keiffer TR, DiGiuseppe S, Guion L, Bienkowska-Haba M, Zwolinska K, Siddiqa A, et al. HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis. Journal of Virology. 2025;99(1). doi:10.1128/jvi.00937-24

BibTeX
@article{Keiffer2025,
  author = {Keiffer, Timothy R and DiGiuseppe, Stephen and Guion, Lucile and Bienkowska-Haba, Malgorzata and Zwolinska, Katarzyna and Siddiqa, Abida and Kushwaha, Anand and Sapp, Martin J},
  title = {HPV16 entry requires dynein for minus-end transport and utilizes kinesin Kif11 for plus-end transport along microtubules during mitosis},
  journal = {Journal of Virology},
  year = {2025},
  volume = {99},
  number = {1},
  doi = {10.1128/jvi.00937-24}
}
Kostenlos starten →